logo
Select company
Select metric
26.81Current Ratio
VS
Market
99
Sector
98
Industry
97
History
88
$ 2.36Close
$ 2 - $ 2.7 52-Week Range
Ticker Information

Ticker

ORMP

Company Name

ORAMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORAMED PHARMACEUTICALS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ORMP - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 99.03M26.81$ 3.69M
3/31/2025$ 131.48M23.94$ 5.49M
12/31/2024$ 143.22M25.19$ 5.68M
9/30/2024$ 142.77M27.08$ 5.27M
6/30/2024$ 153.27M41.06$ 3.73M
3/31/2024$ 177.09M5.28$ 33.56M
12/31/2023$ 162.58M3.06$ 53.21M
9/30/2023$ 175.71M2.25$ 78.17M
6/30/2023$ 150.97M141.49$ 1.07M
3/31/2023$ 155.16M31.21$ 4.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Current Ratio stands at 8.93.
  • Over the past 5 years, ORAMED PHARMACEUTICALS INC's average Current Ratio has been 24.73.
  • The median Current Ratio for ORAMED PHARMACEUTICALS INC during this period was 21.86
  • ORAMED PHARMACEUTICALS INC reached its highest Current Ratio over the past 5 years at 141.49.
  • The lowest Current Ratio recorded by ORAMED PHARMACEUTICALS INC in the same timeframe 2.25

ORAMED PHARMACEUTICALS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
NTRB : NUTRIBAND INC 4.78OTLK : OUTLOOK THERAPEUTICS INC 0.67CNTB : CONNECT BIOPHARMA HOLDINGS LTD 7.24PYXS : PYXIS ONCOLOGY INC 5.65BTAI : BIOXCEL THERAPEUTICS INC 0.76VTGN : VISTAGEN THERAPEUTICS INC 5.98DTIL : PRECISION BIOSCIENCES INC 5.18LGVN : LONGEVERON INC 3.43PLUR : PLURI INC 0.68ADVM : ADVERUM BIOTECHNOLOGIES INC 1.54

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for ORAMED PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 40.51M ] / LiabilitesC [ $ 4.54M ]
(=) Current Ratio [ 8.93 ]

ORMP - Current Ratio, Last 5 years

2.25

Minimum

Sep 30, 2023

141.49

Maximum

Jun 30, 2023

24.73

Average

21.86

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44